PMCR GmbH has developed new, precise, immunological therapy options for cancer patients with the involvement of leading experts from scientific and medical disciplines.

A German SME’s innovation in the field of IT security was registered for a patent and subjected to a quantitative evaluation for further utilisation.

Further development of the business model based on the development of medical polymers for pharmaceutical and biotechnology companies with the goal of investor readiness.